Chaihu Shugan powder restores fatty acid synthesis to alleviate insulin resistance in metabolic syndrome by regulating the LXRα/SREBP-1 signaling pathway
The CSP ameliorated IR in MS by restoring fatty acid metabolism through the regulation of the LXRα/SREBP-1 signaling pathway.
Authors
- Yi‐Mo Deng (ORCID: https://orcid.org/0000-0003-2177-8308)
- Shuai Zhao (ORCID: https://orcid.org/0000-0001-6215-9453)
- Peiying Huang (ORCID: https://orcid.org/0000-0003-4451-1040)
- Liyuan Yu (ORCID: https://orcid.org/0000-0002-8973-7476)
- Lulu Wu
- Meida Wang
- Sisi Lei (ORCID: https://orcid.org/0000-0002-5195-9129)
- Qingchen Li (ORCID: https://orcid.org/0009-0000-3584-2601)
- Weihang Peng
- Bojun Chen
Institutions
- Guangzhou University of Chinese Medicine (CN)
- Guangdong Provincial Hospital of Traditional Chinese Medicine (CN)
- The People's Hospital of Guangxi Zhuang Autonomous Region (CN)
- Center for High Pressure Science & Technology Advanced Research (CN)
- Chenzhou First People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-11-05
- DOI
- https://doi.org/10.3389/fphar.2024.1442279
- Citations
- 3
- Primary Topic
- Cholesterol and Lipid Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 1.72
Funders
- Innovative Research Group Project of the National Natural Science Foundation of China
- National Natural Science Foundation of China